The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 14, 2019
Filed:
Apr. 15, 2016
Applicant:
Ohio State Innovation Foundation, Columbus, OH (US);
Inventor:
Prosper Boyaka, Columbus, OH (US);
Assignee:
Ohio State Innovation Foundation, Columbus, OH (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 39/12 (2006.01); A61P 37/04 (2006.01); A61P 29/00 (2006.01); A61K 9/00 (2006.01); A61K 39/02 (2006.01); A61K 39/07 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/006 (2013.01); A61K 9/0019 (2013.01); A61K 9/0036 (2013.01); A61K 39/00 (2013.01); A61K 39/0291 (2013.01); A61K 39/07 (2013.01); A61K 39/12 (2013.01); A61P 29/00 (2018.01); A61P 37/04 (2018.01); A61K 2039/541 (2013.01); A61K 2039/542 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55527 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/6037 (2013.01);
Abstract
A vaccine composition is disclosed that contains a vaccine antigen and a neutrophil inhibitor in amounts effective to promote an IgA response to the antigen in a subject. Also disclosed is a method for enhancing immune response to a vaccine antigen in a subject that involves co-administering to the subject the vaccine antigen and an adjuvant composition comprising a neutrophil inhibitor in an amount effective to promote an IgA response to the vaccine antigen in the subject.